New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
12:38 EDTUSNA, GOOG, DDD, MYGN, MRK, BIRT, CVS, SSYSOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday after ADP reported that dismal weather in January put a damper on private sector hiring. The market seemed indecisive in the opening 30 minutes of trading, but soon picked up downside momentum. The Nasdaq, which was down more than 1% early in the session, has trimmed its losses and the Dow has moved into positive ground, though just barely. ECONOMIC EVENTS: In the U.S., payroll company ADP reported that 175,000 service jobs were created in January, versus the expectations for 185,000 net new positions to have been added. The ISM services index rose to 54.0 in January from December's 53.0 reading, which was a bit ahead of expectations. COMPANY NEWS: Dow component Merck (MRK) advanced fractionally after the drug company’s quarterly results were generally in-line with expectations and it also announced three clinical collaboration agreements to evaluate its investigational anti-PD-1 immunotherapy… Shares of Google (GOOG) are advancing in a down market after the search giant reached a settlement with European Union regulators over antitrust allegations and research firm Bernstein hiked its price target on the stock to $1,500 from $1,350... CVS Caremark (CVS) announced plans to cease selling all tobacco products, including cigarettes, at all its locations starting October 1. MAJOR MOVERS: Among the notable gainers was multi-level-marketer USANA Health Sciences (USNA), which rose 17% after its results and guidance beat expectations. Also higher were shares of molecular diagnostic company Myriad Genetics (MYGN), which climbed over 11% after the company reported second quarter results that beat consensus expectations, raised its fiscal 2014 outlook, and announced the acquisition of Crescendo Bioscience. Among the noteworthy losers was 3D Systems (DDD), which plunged 16% after the maker of 3D printers and supplies lowered its profit outlook for the current fiscal year and guided to earnings next year below the consensus estimate. A number of 3D Systems’ peers fell as well, with the next biggest company in the sector, Stratasys (SSYS), also declining 3%. Also lower were shares of Actuate (BIRT), which slid about 17% after reporting earnings, announcing the acquisition of German software developer legodo ag and being downgraded at Drexel Hamilton. INDICES: Near midday, the Dow was up 13.12, or 0.08%, to 15,458.36; the Nasdaq was down 13.59, or 0.34%, to 4,017.93; and the S&P 500 was down 2.14, or 0.12%, to 1,753.06.
News For DDD;SSYS;MRK;GOOG;CVS;MYGN;USNA;BIRT From The Last 14 Days
Check below for free stories on DDD;SSYS;MRK;GOOG;CVS;MYGN;USNA;BIRT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
April 7, 2014
05:56 EDTGOOGStocks with implied volatility movement; GOOG XLK
Subscribe for More Information
05:48 EDTMYGNMyriad Genetics submits premarket approval to FDA for BRACAnalysis
Subscribe for More Information
April 6, 2014
17:48 EDTGOOGGoogle set to announce Android TV, The Verge says
Subscribe for More Information
13:37 EDTMRKMerck presents findings on clinical outcomes following treatment with MK-3475
Subscribe for More Information
April 4, 2014
16:38 EDTGOOGGoogle files automatic mixed securities shelf
Subscribe for More Information
11:07 EDTMYGNMyriad Genetics price target raised to $42 from $34 at Piper Jaffray
Piper Jaffray raised its price target for Myriad Genetics shares to $42 to reflect CMS' recent decision to increase BRCA reimbursement. The firm keeps an Overweight rating on the stock.
10:02 EDTMYGNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:22 EDTDDD3D Systems named Best Idea for 2014 at Stephens
Subscribe for More Information
08:31 EDTSSYSStratasys acquires Interfacial Solutions
Subscribe for More Information
08:07 EDTMRKMerck, Ferring announce collaboration with WHO
Merck and Ferring Pharmaceuticals announced their collaboration with the World Health Organization to advance a new, proprietary formulation of carbetocin, used to prevent excessive bleeding in women after childbirth, that is designed to be stable at room temperature, even in hot and tropical climates. Currently, oxytocin, the standard medicine administered for the prevention of excessive bleeding, is temperature-sensitive and requires sustained cold distribution and storage in hot climates. The WHO will conduct a multi-country clinical study to evaluate the effectiveness of room-temperature-stable carbetocin, as compared to oxytocin. The development of a medicine that can be stored at room temperature has the potential to significantly improve management of bleeding following childbirth in the many areas of the world where cold storage is difficult to achieve and maintain, and thereby help reduce maternal deaths in those areas. Starting this year, the study will take place in 12 countries around the world and enroll approximately 29,000 women. If the results of the study are positive, the organizations will work together with the aim of making the medicine available in developing countries that have a high burden of maternal mortality at an affordable and sustainable public-sector price.
07:57 EDTSSYSDeloitte Corporate advising Solid Conceps on sale to Stratasys
Subscribe for More Information
07:55 EDTDDD3D Systems checks indicate strong momentum, says Canaccord
Subscribe for More Information
07:43 EDTGOOGBaidu market leading search share in China rose in March, Marbridge Daily says
Subscribe for More Information
07:42 EDTGOOGGoogle pays $1.4 fine regarding StreetView worries in Italy, Reuters says
Subscribe for More Information
07:28 EDTGOOGNew America Foundation to hold a forum
The New America Foundation holds a forum, "Implementing the PCAST Spectrum Sharing Report" with President Obama's Deputy CTO for Telecom Policy, Jason Furman, VP Medin of Google and Craig Mundie of Microsoft in Washington, D.C. on April 4 at 2 pm. Webcast Link
07:25 EDTGOOGNational Press Club holds a meeting
Subscribe for More Information
06:48 EDTMYGNMyriad Genetics upgraded to Buy from Neutral at Mizuho
Subscribe for More Information
06:46 EDTMYGNMyriad Genetics upgraded to Buy from Neutral at Mizuho
06:22 EDTGOOGNest Labs halts sales of smart smoke alarms
Nest Labs announced it is stopping sales of its Nest Protect: Smoke + Carbon Monoxide alarm because of a defect that can cause owners to inadvertently turn them off. The company says "At Nest, we conduct regular, rigorous tests to ensure that our products are the highest quality. During recent laboratory testing of the Nest Protect smoke alarm, we observed a unique combination of circumstances that caused us to question whether the Nest Wave -- a feature that enables you to turn off your alarm with a wave of the hand -- could be unintentionally activated. This could delay an alarm going off if there was a real fire. We identified this problem ourselves and are not aware of any customers who have experienced this. We feel that the best and safest thing to do is to immediately disable the Nest Wave feature to resolve the issue and remove any safety concerns. While we fix Nest Wave, we have also halted sales of all new Nest Protect alarms to ensure no one buys an alarm that needs an immediate update." Google acquired Nest Labs earlier this year. Reference Link
06:01 EDTGOOGAcacia Research resolves action with Motorola Mobility
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use